Clinical Trial Update: A Study to Test the Safety, Pharmacokinetics, and Efficacy of UCB9741 in Healthy Study Participants and in Study Participants With Atopic Dermatitis [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating the safety, pharmacokinetics, and preliminary efficacy of UCB9741 in healthy participants and in individuals with atopic d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• UCB9741

Snippet

Sponsor: UCB Biopharma SRL | Conditions: Atopic Dermatitis | Phase 1, Phase 2 | Status: COMPLETED